KWSSA02NN3

Milligard^® 0.5/0.2 µm nominal, Opticap^® XL Capsule

Opticap^® XL 2, inlet connection diam. 1/4 in., pore size 0.5/0.2 μm, cartridge nominal length 2 in. (5 cm)

• Synonim(y): Opticap XL 2 with Milligard- 2" 0.5/0.2 μm NPT/NPT 3pk
• Kod UNSPSC: 23151806
• eCl@ss: 32031610

Właściwości

• Materiały: mixed cellulose esters (MCE) ; polyester support; polypropylene ; polypropylene housing; polypropylene vent cap; silicone seal
• Poziom jakości: 400
• zgodność regionalna: meets FDA Indirect Food Additive requirements cited in 21 CFR 177-182 (all component materials)
• sterylność: non-sterile
• Kompatybilność ze sterylizacją: autoclavable compatible
• linia produktu: Opticap^® XL 2
• Właściwości: hydrophilic
• producent / nazwa handlowa: Opticap^®
• Parametry: 1.0 bar max. inlet pressure (15 psi) at 80 °C; 2.75 bar max. inlet pressure (40 psi) at 60 °C; 25 °C max. inlet temp.; 3.5 bar max. differential pressure (50 psid) at 25 °C; 5.5 bar max. inlet pressure (80 psi) at 23 °C; 80 psig max. inlet pressure
• metody: prefiltration: suitable
• Długość: 5.6 in.
• Szerokość: 3.3 in.
• długość nominalna kartridża: 2 in. (5 cm)
• powierzchnia filtracyjna: 0.07 m²
• śr. przyłącza doprowadzającego: 1/4 in.
• śr. przyłącza odprowadzającego: 1/4 in.
• zanieczyszczenia: ≤0.5 EU/mL bacterial endotoxins (LAL test, Aqueous extraction); <0.5 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)
• substancje ekstrahujące się grawimetrycznie: ≤15 mg/capsule
• macierz: Milligard^®
• pore size: 0.5/0.2 μm nominal pore size; 0.5/0.2 μm pore size
• moc wejściowa: sample type liquid
• dopasowywanie: NPT inlet connection; NPT outlet connection; (6 mm (1/4 in.) NPT Inlet and Outlet)

Opis

Opis ogólny

Device Configuration: Capsule

Cechy i korzyści

Format: Double Layer

Opakowanie

Double Easy-Open bag

Inne uwagi

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Directions for Use

• Organism Retention: Microorganism
• Mode of Action: Filtration (size exclusion)
• Application: BioProcessing
• Intended Use: Reduction or removal of microorganism/bioburden
• Instructions for Use: Please refer installation section of OPTICAP^® XL Capsules and OPTICAP^® XLT Capsules user guide
• Storage Statement: Store in dry location
• Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations.

Uwaga dotycząca przygotowania

Sterilization Method
3 autoclave cycles of 30 min @ 121 °C; not in-line steam sterilizable

This product was manufactured with a media combination which meets the criteria for a "non-fiber releasing" filter as defined in 21 CFR 210.3 (b) (6).

Komentarz do analizy

Gravimetric Extractables: after 24 hours in water at controlled room temperature

Informacje prawne

MILLIGARD is a registered trademark of Merck KGaA, Darmstadt, Germany

OPTICAP is a registered trademark of Merck KGaA, Darmstadt, Germany

Oświadczenie o zrzeczeniu się odpowiedzialności

EMD Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive, 97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe use. In compliance with Article 3 § 3 of this Pressure Vessel Directive, this product does not bear the CE mark.

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 4.1B - Flammable solid hazardous materials
• Klasa zagrożenia wodnego (WGK): WGK 3